Cargando…
Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER
OBJECTIVE: To evaluate abuse, misuse, and diversion of Xtampza ER, an extended-release (ER) abuse-deterrent formulation (ADF) of oxycodone. METHODS: Abuse, misuse, and diversion of Xtampza ER were assessed using Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System data sour...
Autores principales: | Geoffrey Severtson, Stevan, Kreider, Scott E D, Amioka, Elise C, Margolin, Zachary R, Iwanicki, Janetta L, Dart, Richard C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770232/ https://www.ncbi.nlm.nih.gov/pubmed/33094329 http://dx.doi.org/10.1093/pm/pnaa272 |
Ejemplares similares
-
Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)
por: Vosburg, Suzanne K, et al.
Publicado: (2019) -
Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Chaves, Carolina, et al.
Publicado: (2020) -
Correlates of patterns of cannabis use, abuse and dependence: evidence from two national surveys in Ireland
por: Millar, Seán R, et al.
Publicado: (2021) -
A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
por: Jewell, Jennifer, et al.
Publicado: (2023) -
Correction to: A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
por: Jewell, Jennifer, et al.
Publicado: (2023)